Experimental Diabetes Drug

By Health Day – Re-Blogged From Newsmax Health

An experimental drug may help people with type 2 diabetes curb their blood sugar without causing it to drop to dangerously low levels.

Researchers found that the compound — dubbed TTP399 for now — improved patients’ blood sugar control when it was added to the standard medication metformin for six months. And it did so without causing hypoglycemia — blood sugar drops that, if severe, can lead to convulsions or loss of consciousness.

The findings, published Jan. 16 in the journal Science Translational Medicine, come from an earlier Phase 2 trial. And more research is needed before TTP399 can be added to existing armaments against type 2 diabetes, said senior researcher Carmen Valcarce.

Continue reading

FDA OKs 1st Migraine Drug

By Associated Press – Re-Blogged From Newsmax Health

The FDA has approved the first drug designed to prevent chronic migraines. Aimovig is injected monthly just under the skin using a pen-like device and will cost $6,900 per year without insurance.

The Food and Drug Administration’s action clears the monthly shot for sale. Aimovig is the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several pills for preventing migraines are being tested.

Continue reading